Glucose Transporter |
|
|
Cat. No. |
Product |
Action |
Inhibitors |
6199 |
BAY
876 |
Potent
and selective GLUT1 inhibitor |
6100 |
Fasentin |
GLUT1/GLUT4
inhibitor; also Fas-sensitizer |
4484 |
STF
31 |
GLUT1
inhibitor; also NAMPT inhibitor |
6143 |
WZB
117 |
GLUT
inhibitor |
Other |
6065 |
2-NBDG |
Fluorescent
glucose uptake indicator |
7447 |
SCOTfluor
glucose probe 510 |
Fluorescent
glucose probe |
|
|
|
|
Multidrug Transporter |
|
|
Cat. No. |
Product |
Action |
Inhibitors |
5867 |
Ceefourin
1 |
Selective
MRP4 inhibitor |
4193 |
CP
100356 hydrochloride |
P-gp
inhibitor |
4646 |
Elacridar
hydrochloride |
P-gp
and BCRP inhibitor |
2876 |
Fumitremorgin
C |
Inhibitor
of BCRP-mediated multidrug resistance |
3241 |
Ko
143 |
Potent
and selective BCRP inhibitor |
4169 |
KS
176 |
Selective
BCRP inhibitor |
2338 |
MK
571 |
MRP1
inhibitor; also CysLT1 (LTD4) inverse agonist |
2891 |
Ondansetron
hydrochloride |
Potent
MATE1 inhibitor |
4107 |
Probenecid |
MRP
and OAT3 inhibitor |
4042 |
PSC
833 |
Inhibitor
of P-gp-mediated MDR |
6885 |
PU
23 |
Multidrug
resistance protein (MRP) 4 inhibitor |
3918 |
Pyrimethamine |
Potent
inhibitor of multidrug and toxin extrusion (MATE) transporters; also DHFR and STAT3 inhibitor |
3722 |
Reversan |
Selective
MRP1 and P-gp inhibitor |
5757 |
Tariquidar
dihydrochloride |
Potent
P-glycoprotein (P-gp) inhibitor |
5456 |
Zosuquidar
trihydrochloride |
High
affinity P-gp inhibitor |
Substrates |
5119 |
Calcein
AM |
Substrate
for MDR |
4936 |
Clozapine
N-oxide |
Metabolite
of clozapine (Cat. No. 0444); shown to be a P-gp efflux pump substrate |
6329 |
Clozapine
N-oxide dihydrochloride |
Water
soluble salt of Clozapine N-oxide (Cat. No. 4936); shown to be a P-gp efflux
pump substrate |
4054 |
PEP
005 |
Substrate
for MDR; also protein kinase C activator |
|
|
|
|
K+/Cl-Cotransporter 2 |
|
|
Cat. No. |
Product |
Action |
Inhibitor |
3888 |
VU
0240551 |
KCC2
inhibitor |
4719 |
VU
0463271 |
Potent
and selective KCC2 inhibitor |
Activator |
5242 |
CLP
257 |
Selective
KCC2 activator |
6758 |
CLP
290 |
K+/Cl-
cotransporter 2 (KCC2) activator; orally bioavailable prodrug of (Cat.No.
5242) |
|
|
|
|
Monocarboxylate Transporter |
|
|
Cat. No. |
Product |
Action |
Inhibitor |
5658 |
AR-C 141990 hydrochloride |
MCT1
inhibitor |
4960 |
AR-C155858 |
MCT1
and MCT2 inhibitor; inhibits glycolysis in cancer cells |
6817 |
BAY 8002 |
Potent
dual MCT1/2 inhibitor; orally bioavailable |
7512 |
3-Bromopyruvate |
MCT1
inhibitor; also inhibits hexokinase II |
5029 |
CHC |
MCT
inhibitor; decreases glycoloysis |
5431 |
SR 13800 |
Potent
MCT1 inhibitor |
4186 |
UK 5099 |
MCT
inhibitor; also inhibits mitochondrial pyruvate carrier |